Key result
Only 15.4% of surveyed medical and dental practitioners favored continuing antithrombotic medication without alteration, and less than half (35.3%) used current guidelines for managing such patients.
Why the study?
What is the knowledge level of medical and dental practitioners regarding the dental management of patients on anticoagulant and/or antiplatelet therapy?
Cross-Sectional (n=543)
Yes
What is the knowledge level of medical and dental practitioners regarding the dental management of patients on anticoagulant and/or antiplatelet therapy?
There is a significant knowledge gap among medical and dental practitioners regarding the evidence-based management of patients on antithrombotic therapy undergoing dental procedures.
Low guideline adherence in antithrombotic management warrants education; leaves open effects on bleeding and thrombotic outcomes.
Objective: The purpose of this study was to evaluate the knowledge of medical and dental practitioners towards the dental management of patients who are on anti-coagulant and/or anti platelet agents. Methods: This study was conducted in different hospitals/health centers of Riyadh and AlKharj cities, Saudi Arabia. Participants included practitioners working in government and private medical centers/hospitals. A self-administered questionnaire including details about the practitioners’ level of education and work experience was used. Participants were asked questions regarding dental management of patients on anticoagulant therapy and/or antiplatelet therapy. Result: A total of 650 self-administered questionnaires were distributed among dental and medical practitioners, of which, 543 were returned complete. Most of the participants were general (graduate) medical and dental practitioners (59.3%). 15.4% practitioners were in favor of continuing the antiplatelet or anticoagulant medication without alteration while 6.6% were unsure about stopping or continuing the medication. A less than half (35.3%) of the practitioners were using current guidelines for managing such patients. Dentist (58.6%) and medical practitioners (64.7%) felt that evidence based guidelines would be helpful in dental management of patients on antithrombotic therapy. Conclusion: Dentists and medical practitioners showed a wide range of approach in terms of knowledge related to management of patient taking anticoagulant and/or antiplatelet medication prior to dental treatment. There is a need to educate both medical and dental practitioners to use evidence based guidelines for management of such patients.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2014) conducted a cross-sectional in Medical and dental practitioners (n=543). Knowledge of dental management of patients on anticoagulant/antiplatelet therapy was evaluated on Knowledge and approach towards continuing/stopping medication and use of guidelines. Only 15.4% of surveyed medical and dental practitioners favored continuing antithrombotic medication without alteration, and less than half (35.3%) used current guidelines for managing such patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: